University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that ...
Tag: Drug Development
Thin Film Freezing Shows Efficacy for Biodefense Countermeasures Against Alphaviruses and Filoviruses
TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented thin-film ...
Macaques Develop Promising Immune Response to SARS-CoV-2
In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 ...
New Vaccine Development Platform Could Fight Deadly, Multi-Drug Resistant Bacteria
A new vaccine development platform has proven effective in protecting against deadly, hard-to-treat infections caused by multi-drug resistant bacteria, thanks ...
Why Combining the Oxford COVID-19 Vaccine with Russia’s Sputnik V Could Make It More Effective
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of ...
Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development
In the medical and military fields, antibiotic-resistant bacteria can be formidable foes. Now, University of Florida Health researchers and their ...
Novel Inhaled Vaccine for Tuberculosis Shows Strong Immune Response in Mice
New method to assist fast-tracking of vaccines for pre-clinical tests Scientists in Australia have developed a method for the rapid ...
Artificial Intelligence Collaboration Seeking to Hasten COVID-19 Insights
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to ...
Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine
Altimmune Inc. has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to commence a Phase ...
NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates
With multiple promising SARS-CoV-2 vaccine candidates now under development, the National Institute of Allergy and Infectious Diseases (NIAID) is looking ...
Stopping Lethal Lung Damage from Influenza: MG53 Protein Shows Promise in Animal Models
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a ...
Scientists Engineer Bacteria-Killing Molecules from Wasp Venom
Novel antibiotics are urgently needed to treat the ever-increasing number of drug-resistant infections. Venoms constitute a treasure trove of novel ...
NIH Funds a $9.3M Center for Precision Animal Modeling at UAB
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a ...
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation
In a new study, researchers from the Dangerous Pathogens Team at CSIRO conclude vaccines currently under development for COVID-19 should ...
Renowned Tick Immunobiologist to Develop Lyme Disease Vaccine Under New $3.5M Federal Grant
Dr. Utpal Pal wants to adapt the rabies vaccination platform to produce antibodies that can protect against Borrelia burgdorferi, the ...
Why It Matters That the U.S. Is Not Supporting COVAX
There is a global effort to distribute vaccines to poorer countries, but some of the world’s largest countries, including the ...
HHS Pushes Out COVID-19 Mass Vaccination Playbook, Distribution Strategy
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today released new documents outlining the ...
The Big 3 Infectious Diseases Besides COVID-19 Scientists Are Trying to Find a Vaccine For
More than 28 million people around the world have now contracted COVID-19, and more than 900,000 people have died. Research ...
COVID-19 Industry Rivals Plan Joint Pledge on Vaccine Safety
Several drug makers developing vaccines to counter SARS-CoV-2 plan to issue a public pledge not to seek government approval until ...
Lessons From Hydroxychloroquine: Improving FDA’s Authorization and Approval Process
On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use ...
